ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,071, issued on Jan. 28, was assigned to AlzeCure Pharma AB (Huddinge, Sweden).
"Triazine derivatives for treating diseases relating to neurotrophins" was invented by Gunnar Nordvall (Ronninge, Sweden) and Pontus Forsell (Huddinge, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided herein a compound of formula I,wherein R1, R2, n, X, Q, L, m, R3 and p are as defined herein, which compounds are useful in the treatment of treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like."
The patent was filed on June 2, 2022, under Application No. 17/...